Daniel Montes, MD
Hospital Medicine
Accepting new patients
Sees patients age 18 and up
Penn Hospital Medicine HUP
View 1 additional location
Penn Medicine Provider

About me

  • Clinical Assistant Professor of Medicine (Hospital Medicine)
  • Instructor A of Medicine (Hospital Medicine)

Education and training

  • Medical School: University of Wisconsin School of Medicine and Public Health
  • Residency: Mayo Clinic

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
Dr. Montes is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Montes D, Weerasiri SD, Suarez MG. 60-Year-Old Man With Low Hemoglobin and Elevated Creatinine Levels , Mayo Clin Proc, 100(5): 2025,895-899


Montes D, Schmitz JJ, Paisansinsup T, Warrington KJ, Koster MJ. Use of occipital artery ultrasound to diagnose and monitor response to therapy in a patient with giant cell arteritis , Clin Exp Rheumatol, 43(4): 2025,762-763


Kalantari K, Sullivan MM, Herrera Hernandez LP, Bu L, Cornell LD, Nasr SH, Fervenza FC, Montes D, Mangaonkar AA, Go RS, Kusne YN, Patnaik MM, Lasho TL, Olteanu H, Reichard KK, Warrington KJ, Koster MJ. Acute kidney injury, an underrecognized feature of VEXAS syndrome , Rheumatology (Oxford), 64(4): 2025,2027-2033


Montes D, Bohrer NE, Warrington KJ, Koster MJ. Large-vessel imaging in patients with giant cell arteritis with scalp involvement: A commentary on giant cell arteritis associated with scalp, tongue or lip necrosis in a French multi-center case control study , Semin Arthritis Rheum, 68: 2024,152512


Montes D, Hanson A, Langenfeld H, Crowson C, Patnaik M, Go R, Hines A, Kalantari K, Kusne Y, Lasho T, Mangaonkar A, Olteanu H, Reichard K, Sullivan M, Viswanatha D, Warrington K, Koster M. Developing Predictive Models for the Diagnosis of VEXAS Syndrome , Arthritis Rheumatol. ACR Convergence 2024 – Oral Presentation, 76(9): 2024


Fernandez JA, Kusne Y, Gutierrez-Rodrigues F, Patel BA, Finke C, Groarke EM, Koster MJ, Mangaonkar AA, Gangat N, Warrington K, Reichard KK, Olteanu H, Viswanatha D, He R, Sullivan M, Kalantari K, Hines A, Montes D, Young NS, Beck DB, Mohammed WI, Gaspar-Maia A, Lasho TL, Patnaik MM DNMT3A Mutant Clonal Hematopoiesis in Vexas Syndrome Epigenetically Potentiates IL-13 and IL-15 Inflammatory Pathways and Is Associated with Increased Mortality. , Blood 2024, 144(1): 2024,2686


Sullivan M, Kalantari K, Mead-Harvey C, Kusne Y, Patnaik M, Mangaonkar A, Go R, Montes D, Reichard K, Olteanu H, Bois M, Hines A, Sartori-Valinotti J, Warrington K, Koster M. Vasculitis Associated with VEXAS Syndrome , Arthritis Rheumatol. ACR Convergence 2024 – Oral Presentation , 76(9): 2024


Montes D, Myasoedova E, Kodishala C, George R, Hanson A, Kronzer V, Davis J, Crowson C. Increased Social Vulnerability Index Predicts Lower Likelihood of Remission in Rheumatoid Arthritis Patients , Arthritis Rheumatol. ACR Convergence 2024. Poster Presentation, 76(9): 2024


Montes D, Bohrer N, Koster MJ. Not off the top of my head: A case of Giant Cell Arteritis Presenting as Inflammatory Scalp Nodules , 10th Annual Mayo Clinic Annual Rheumatology Review for Primary Care, Poster Presentation: 2024


Kneeland R, Montes D, Endo J, Shields B, Bartels CM, Garg S. Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and Meta-Analysis , Arthritis Care Res (Hoboken), 75(8): 2023,1838-1848